TMC
GHDX

Trellus Management Company’s Genomic Health, Inc. GHDX Stock Holding History

Trellus Management Company’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-15,000
Closed -$372K – 83
2016
Q1 		$372K Buy
+15,000
New +$412K 0.65% 39

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Trellus Management Company's GHDX Position: Q2 2016 in Review

Trellus Management Company sold out of Genomic Health, Inc. (GHDX) in Q2 2016, closing a stake of 15,000 shares — an estimated $372K sold.

Trellus Management Company first reported a position in GHDX in Q1 2016 and held it in 1 quarter. The position peaked at $372K in Q1 2016. 130 funds tracked by Wall St. Rank hold GHDX as of Q2 2016.

  • Trellus Management Company reported no remaining Genomic Health, Inc. position as of Q2 2016 after selling out during the quarter.
  • Trellus Management Company sold 15,000 Genomic Health, Inc. shares in Q2 2016, an estimated $372K.
  • Trellus Management Company first reported a position in Genomic Health, Inc. in Q1 2016 and held it in 1 quarter.
  • Trellus Management Company's Genomic Health, Inc. position peaked at $372K in Q1 2016.
  • 130 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2016.

Based on Trellus Management Company's 13F filing for Q2 2016, filed 18 Jul 2016.